ArticleMolecular therapy. Oncology2026
mRNA vaccination using peptide nanoparticles triggers a strong immune response against endogenous GPC2 in a murine neuroblastoma model.
Ellen King et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.